Nephrogen vs Lendtable
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 preclinical gene therapy for polycystic kidney disease (600K US patients) using AI-driven target identification; $1.1M raised with NIH SBIR grant, raising $4M seed competing with CRISPR Therapeutics for curative kidney genetic medicine.
About
Nephrogen is a San Francisco-based preclinical gene therapy company — backed by Y Combinator (W20) with $1.1 million in total funding including $775,000 raised to date plus a $325,000 NIH SBIR grant, and currently raising a $4 million seed round with support from StartX and 2048 Ventures — developing curative gene therapies for kidney diseases, with polycystic kidney disease (PKD) as the lead program targeting the 600,000 Americans with the autosomal dominant PKD subtype, an inherited kidney cyst disorder with no disease-modifying treatments that currently progresses to end-stage renal disease requiring dialysis or transplant in the majority of patients. Founded by researchers with combined expertise in AI-driven drug discovery, genetic engineering, and nephrology, Nephrogen applies AI target identification and gene therapy delivery to the largest category of rare inherited kidney diseases.
SF fintech providing credit to help employees fully capture 401(k) employer match and ESPP benefits; $72.3M YC-backed with SoftBank investment at Microsoft, Google, Amazon employees.
About
Lendtable is a San Francisco-based fintech company providing lines of credit to salaried employees to fully capture their employer 401(k) match and ESPP (Employee Stock Purchase Plan) benefits — solving the underutilization problem where employees who can't afford to divert sufficient paycheck to 401(k) contributions leave matching employer funds uncaptured. Founded and backed by Y Combinator (W20) with $72.3 million raised including an $18 million Series A led by O1 Advisors with participation from SoftBank's SB Opportunity Fund and Valor Equity Partners, Lendtable has disbursed over $2.4 million in match benefits to employees at Microsoft, Google, Amazon, and IBM.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.